| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.9B | $42.2B | $47.7B | $59.0B | $31.3B | $4.7B | $9.4B | $10.0B |
| Cost of Revenue | $36.0B | $41.1B | $46.7B | $58.0B | $30.5B | $19.5B | $35.7B | $38.7B |
| Gross Profit | $0.9B | $1.0B | $1.1B | $1.1B | $0.8B | $0.2B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.6B | $0.2B | $0.2B | $0.3B | $0.1B | $0.1B | $0.3B | $0.3B |
| Net Income | $-0.6B | $0.1B | $0.1B | $0.1B | $0.1B | $-0.0B | $0.1B | $0.1B |
| EPS (Basic) | $-10.99 | $1.14 | $0.86 | $1.83 | $1.17 | $-0.06 | $0.86 | $0.44 |
| EPS (Diluted) | $-10.99 | $1.13 | $0.86 | $1.82 | $1.16 | $-0.06 | $0.86 | $0.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.9B | $6.7B | $7.4B | $8.2B | $5.9B | $4.5B | $6.0B | $5.7B |
| Current Assets | $3.5B | $4.0B | $4.5B | $5.2B | $4.0B | $2.6B | $4.2B | $4.0B |
| Cash & Equivalents | $0.2B | $0.4B | — | — | — | — | $0.2B | $0.2B |
| Total Liabilities | $4.6B | $4.8B | $5.4B | $6.2B | $4.0B | $2.6B | $4.1B | $3.8B |
| Current Liabilities | $3.3B | $3.4B | $4.0B | $4.6B | $3.1B | $1.7B | $3.2B | $2.9B |
| Stockholders' Equity | $1.3B | $1.9B | $1.9B | $2.0B | $1.9B | $1.9B | $1.9B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.1B | $0.2B | $0.6B | $0.2B | $-0.2B |
| Investing Cash Flow | $-0.2B | $0.1B | $-0.1B | $-0.7B | $-0.1B | $0.1B | $-0.1B | $0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.2B | $-0.2B | $0.2B | $-0.1B | $-0.2B | $-0.2B | $-0.3B |